Mirradol t.z. "mirra"

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.001363.03.16
Date of registration and renewal:25.03.2016
Dosage form: & nbsptablets weighing 0.7 grams
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp Supplements of various groups
Composition: & nbspBiologically active substances, mg / tab., Not less: hydroquinone - 1,4, vitamin B2 - 0,016.

yeast extract, E460i, epopen, E470a.
Scope: & nbspfor realization to the population as biologically active additive to food - an additional source of hydroquinone containing vitamin B2.
Suggested Usage: & nbspadults 5 tablets 2 times a day with meals. Duration of admission is 15 days.
Contraindications:individual intolerance of components, pregnancy, breast-feeding. Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in a dry place, protected from light, out of reach of children, at a temperature of no higher than 25 ° C.
Research protocols:expert conclusion of the Federal State Research Institution "NII Nutrition" No. 72 / E-1647 / b-15 of December 24, 2015.
Recipient:Mirra-M, ZAOMirra-M, ZAO Russian Federation
Information update date: & nbsp05.04.2016
Instructions
Up